Modulating influence of cytochrome P-450 MspI polymorphism on serum liver function profiles in coke oven workers

Wu, M.T.; Ho, C.K.; Huang, S.L.; Yeh, Y.F.; Liu, C.L.; Mao, I.F.; Christiani, D.C.
March 1999
Occupational & Environmental Medicine;Mar1999, Vol. 56 Issue 3, p159
Academic Journal
journal article
Objectives: It was reported previously that topside oven workers with heavy exposure to coke oven emissions had increased serum activities of hepatic aminotransferase in one coke oven plant. This study was conducted to investigate the modifying effect of CYP1A1 MspI polymorphism on liver function profiles in coke oven workers.Methods: 88 coke oven workers from a large steel company in Taiwan were studied in 1995-6. Exposure was categorised by work area: topside oven workers and sideoven workers. Liver function profiles including serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), r-glutamyl transpeptidase (GGT), alkaline phosphatase (ALP), and total bilirubin (BIL) were examined in the morning after personal exposure measurements. The MspI polymorphism was determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP).Results: Five of 23 (22%) topside oven workers and seven of 65 (11%) sideoven workers had the CYP1A1 MspI homozygous variant genotype. With sideoven workers with the combined wild type and heterozygous variant as the reference group in multiple regression models, it was found that topside oven workers with the combined traits had mean AST and ALT activities that were 21% and 46% higher (95% confidence interval (95% CI) 4% to 42% and 12% to 91%, respectively) than the reference group after adjusting for appropriate confounders. Also, topside oven workers with the homozygous variant trait had mean AST, ALT, and GGT activities that were 59%, 68%, and 157% higher (95% CI 21% to 109%, 6% to 168%, and 39% to 374%, respectively) than the reference group. The prevalence of an abnormal hepatocellular pattern (AST > 37 IU/l or ALT > 39 IU/l) was more common in the topside oven workers with the homozygous variant than in the sideoven workers with the other combined genotypes (adjusted odds ratio 9.9, 95% CI 1.2 to 82.3) after adjusting for appropriate confounders.Conclusions: The CYP1A1 MspI polymorphism may modify the biotransformation of coke oven emissions, which results in hepatocellular damage in coke oven workers.


Related Articles

  • The Determination of Metabolite M17 and Its Meaning for Immunosuppressive Cyclosporin Therapy. Khoschsorur, G.; Auer, T.; Lanzer, G.; Petritsch, P.; Holzer, H.; Tscheliessnigg, K. H. // Angiology;Apr1998, Vol. 49 Issue 4, p307 

    Cyclosporin A (CyA) is intensively metabolized by the hepatic cytochrome p450 III monooxygenase A system in the human liver, the most important metabolites being M1, M17, and M21. Because CyA and its metabolites have nephrotoxic, hepatotoxic, and neurotoxic side effects, CyA dosage must be...

  • Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population. Imaizumi, Takeshi; Higaki, Yasuki; Hara, Megumi; Sakamoto, Tatsuhiko; Horita, Mikako; Mizuta, Toshihiko; Eguchi, Yuichiro; Yasutake, Tsutomu; Ozaki, Iwata; Yamamoto, Kyosuke; Onohara, Shingo; Kawazoe, Seiji; Shigematsu, Hirohisa; Koizumi, Shunzo; Kudo, Sho; Tanaka, Keitaro // Carcinogenesis;Oct2009, Vol. 30 Issue 10, p1729 

    Limited epidemiological evidence suggests that genetic polymorphisms of drug-metabolizing enzymes such as cytochrome P450 (CYP), glutathione S-transferase (GST) and N-acetyltransferase (NAT) may be involved in tobacco-related hepatocarcinogenesis. We conducted a case–control study,...

  • Effects of liver disease on pharmacokinetics. An update. Rodighiero, V. // Clinical Pharmacokinetics;1999, Vol. 37 Issue 5, p399 

    Liver disease can modify the kinetics of drugs biotransformed by the liver. This review updates recent developments in this field, with particular emphasis on cytochrome P450 (CYP). CYP is a rapidly expanding area in clinical pharmacology. The information currently available on specific isoforms...

  • Liver disease selectively modulates cytochrome P450—mediated metabolism*. Frye, Reginald F.; Zgheib, Nathalie K.; Matzke, Gary R.; Chaves-Gnecco, Diego; Rabinovitz, Mordechai; Shaikh, Obaid S.; Branch, Robert A. // Clinical Pharmacology & Therapeutics;Sep2006, Vol. 80 Issue 3, p235 

    Background: The liver plays a significant role in drug metabolism; thus it would be expected that liver disease may have a detrimental effect on the activity of cytochrome P450 (CYP) enzymes. The extent to which the presence and severity of liver disease affect the activity of different...

  • Acute, Short-Term, and Subchronic Oral Toxicity of 1,1,1-Trichloroethane in Rats. Bruckner, James V.; Kyle, Glenna M.; Luthra, Raja; Acosta, Daniel; Mehta, Sanjay M.; Sethuraman, Sankar; Muralidhara, Srinivasa // Toxicological Sciences;Apr2001, Vol. 60 Issue 2, p363 

    1,1,1-Trichloroethane (TRI) is a widely used solvent that has become a frequent contaminant of drinking water supplies in the U.S. There is very little information available on the potential for oral TRI to damage the liver or to alter its P450 metabolic capacity. Thus, a major objective of this...

  • Cytochrome P450 and Liver Diseases. Villeneuve, J.-P.; Pichette, V. // Current Drug Metabolism;Jun2004, Vol. 5 Issue 3, p273 

    Cytochrome P-450 (CYPs) are involved in the metabolism of drugs, chemicals and endogenous substrates. The hepatic CYPs are also involved in the pathogenesis of several liver diseases. CYP-mediated activation of drugs to toxic metabolites induces hepatotoxicity. Well-known examples include...

  • Evaluation of Time-Dependent Cytochrome P450 Inhibition in a High-Throughput, Automated Assay: Introducing a Novel Area Under the Curve Shift Approach. Mukadam, Sophie; Tay, Suzanne; Tran, Daniel; Wang, Leslie; Delarosa, Erlie M.; Khojasteh, S. Cyrus; Halladay, Jason S.; Kenny, Jane R. // Drug Metabolism Letters;Mar2012, Vol. 6 Issue 1, p43 

    Early in the drug discovery process, the identification of cytochrome P450 (CYP) time-dependent inhibition (TDI) is an important step for compound optimization. Here we describe a high-throughput, automated method for the evaluation of TDI utilizing human liver microsomes and conventional...

  • Nonparametric expectation maximisation (NPEM) population pharmacokinetic analysis of caffeine disposition from sparse data in adult caucasians: systemic caffeine clearance as a biomarker for cytochrome P450 1A2 activity. Terziivanov, Dimiter; Bozhinova, Kristina; Dimitrova, Velislava; Atanasova, Ivanka // Clinical Pharmacokinetics;Dec2003, Vol. 42 Issue 15, p1393 

    Objective: To explore the ability of the nonparametric expectation maximisation (NPEM) method of population pharmacokinetic modelling to deal with sparsedata in estimating systemic caffeine clearance for monitoring and evaluation of cytochrome P450 (CYP) 1A2 activity. Design and participants:...

  • Metabolism and hepatic toxicity of flutamide in cytochrome P450 1A2 knockout SV129 mice. Matsuzaki, Yasushi; Nagai, Daichi; Ichimura, Eiji; Goda, Rika; Tomura, Arihiro; Doi, Mikio; Nishikawa, Kiyohiro // Journal of Gastroenterology;Mar2006, Vol. 41 Issue 3, p231 

    Background. Flutamide, a nonsteroidal antiandrogen used for treatment of prostate cancer, causes a temporary increase in transaminase and in some cases severe liver dysfunction. It is dominantly metabolized by cytochrome P450 (CYP) 1A2 into 2-hydroxyflutamide (OH-flutamide), which has stronger...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics